An observational study of nab-paclitaxel-induced peripheral neuropathy

An observational study of nab-paclitaxel-induced peripheral neuropathy - An observational study of nab-paclitaxel-induced peripheral neuropathy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020852

Enrollment

100

Registered

2016-02-15

Start date

2013-08-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: (1)Patients are histologically proven breast cancer (2) Scheduled to receive nab-paclitaxel as primary systemic therapy for breast cancer (3)Sensory neuropathy(grade)0-1 (4)Patients are previously treated with a taxane-containing regimen

Exclusion criteria

Exclusion criteria: (1)Physician concludes that the patient's participation in this trial is inappropriate

Design outcomes

Primary

Measure	Time frame
The long-term outcome of nab-paclitaxel-induced peripheral neuropathy	—

Secondary

Measure	Time frame
(1)The validity of neuropathic pain screening tool (2) To evaluate the effect of frozen globes and elastic stockings for nab-paclitaxel-induced peripheral neuropathy	—

Countries

Japan

Contacts

Public ContactKatsuhide Yoshidome

Osaka Police Hospital Department of Breast Surgery

oph@live.jp0667716051

Outcome results